Cepheid Gets Canadian Clearance of MRSA/SA Test | GenomeWeb
NEW YORK (GenomeWeb News) – Cepheid today said that Canadian regulatory authorities have cleared for marketing the firm’s molecular diagnostic assay for methicillin-resistant Staphylococcus aureus and Staphylococcus aureus in skin and soft tissue infections.
 
The Xpert MRSA/SA SSTI test runs on Cepheid’s GeneXpert System and can provide test results in less than an hour. The firm noted that its test is the first molecular SSTI diagnostic for MRSA and SA to be cleared in Canada.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.